Hexa Health Benefits
Trusted Doctors and Top Hospitals
Consultations with expert surgeons
Extensive assistance throughout your treatment
Book Consultation
Burkitt lymphoma is well-known for its rapid growth. It is one of the quickest-growing human tumours, with cells expanding fast and tumours increasing in size, sometimes within 24 to 48 hours. Burkitt’s lymphoma presents itself geographically.
Burkitt’s lymphoma is caused by a malignant development of lymphoid tissue and usually manifests as a massive tumour of the jaw. It is, however, a rare occurrence in the Indian subcontinent. Continue reading to learn more about Burkitt lymphoma translocation, symptoms, causes, treatment, etc.
Disease Name | Burkitt Lymphoma |
Symptoms | Enlarged lymph node, Fever, Unusual weight loss, Night sweats, Fatigue |
Causes | Epstein-Barr Virus, HIV, Genetics, Weak immunity, Age |
Diagnosis | Cerebrospinal Fluid Cytology, CT scan, PET scan, LDH Test |
Treated by | Haemato-oncologist |
Treatment Options | Chemotherapy, Radiation therapy, Immunotherapy, Stem cell transplant |
Burkitt lymphoma (BL) is a severe non-Hodgkin lymphoma. Burkitt lymphoma histology often shows a widespread expansion of medium-sized, non-cleaved B cells with a high maturation rate.
The condition is linked to Epstein-Barr virus (EBV), HIV, and chromosomal translocations that result in the amplification of the oncogene c-myc. Patients with Burkitt lymphoma frequently have an MYC-simple Burkitt’s lymphoma karyotype (a person's entire set of chromosomes).
Burkitt's non-hodgkin's lymphoma is endemic in places like Brazil, Papua New Guinea, and equatorial Africa, where malaria is holoendemic (a condition in which a high prevalence level of infection starts early in life and impacts the majority of the youth population).
Burkitt lymphoma makes up about 1% to 5% of all non-Hodgkin lymphomas. BL, like most kinds of lymphoma, is more common in men, with a 3 to 4:1 male-to-female ratio.
Burkitt lymphoma is distinguished by genetic abnormalities, most notably chromosomal translocations affecting the MYC gene (a family of genes that makes proteins for several cell functions). These Burkitt lymphoma translocations cause overexpression of the MYC oncogene, essential for cell proliferation and division.
The most prevalent translocation in Burkitt’s lymphoma is t(8;14)(q24;q32), which occurs when the MYC gene on chromosome 8 meets the immunoglobulin heavy chain gene (IGH) on chromosome 14. This translocation causes the MYC gene to be imbalanced and overexpressed, causing unusual cell growth and the development of tumors.
While translocations involving MYC are indicative of Burkitt lymphoma, they are not limited to this illness and can be detected in other lymphomas and malignancies.In Indian children, Burkitt Lymphoma accounts for just 0.76% of solid malignant tumours, making it a very uncommon form of cancer. Geographical location and the body sections it impacts are two factors that distinguish the types of Burkitt’s lymphoma, which are:
Endemic: Africa is the region of origin for endemic Burkitt lymphoma. It is also the most common Burkitt lymphoma of all childhood cancers. The jaw is where endemic illness most frequently manifests. It has been established that the endemic variant of Burkitt lymphoma is associated with the Epstein-Barr virus (EBV).
Sporadic: The sporadic form of Burkitt lymphoma exists worldwide. However, it contributes to 30% of all children's lymphoma. The most typical location for this type of Burkitt's lymphoma to manifest itself is an abdominal tumour.
Immunodeficiency-Related: People with acquired immunodeficiency syndrome (HIV/AIDS) are more susceptible to this cancer. Additionally, it can happen to people who take immunosuppressive drugs to avoid organ rejection after transplantation or those who have inherent immune weaknesses.
World Health Organization (WHO) classification system is generally used to stage Burkitt lymphoma. This approach considers how far a disease has spread and aids in selecting the most effective Burkitt lymphoma treatment guidelines. The following describes the Burkitt lymphoma staging:
Stage 1: When the cancer is contained in one lymph node area or one organ outside the lymphatic system, it is said to be in stage one.
Stage 2: Cancer may affect two or more lymph node areas on the same side of the diaphragm, or it may only affect one lymph node region and a nearby organ.
Stage 3: The spleen, liver, bone marrow, or other extra lymphatic organs have all been affected by the spread of cancer cells as well as lymph node regions on both sides of the diaphragm.
Stage 4: The central nervous system (brain and spinal cord), bone marrow, or other organs outside the lymphatic system have all been affected by the cancer's spread.
Depending on the type, Burkitt lymphoma has different symptoms. In the endemic (African) variation, tumours of the jaw or other bones in the face are frequently the first signs.
Sporadic and immune-deficiency-related typically begin in the intestine and develop into a large tumour mass in the abdomen, frequently including the liver, spleen, and bone marrow heavily.
Other Endemic Burkitt’s Lymphoma Symptoms
Fast lymph node expansion
Tumours size doubling quickly
Fever
Unusual weight loss
Extreme fatigue
Nausea
Other Immune-deficiency-related and Sporadic Burkitt’s Lymphoma Symptoms
Sweating during the night
Intestinal obstruction
An enlarged thyroid
Oversized tonsils
Expert Doctors (10)
NABH Accredited Hospitals (10)
Burkitt’s lymphoma's specific cause is unknown. However, some individuals have a higher risk of developing the disease than others. Here are some common causes:
Epstein-Barr Virus (EBV): Strong links exist between Epstein-Barr virus infection and the endemic type of Burkitt lymphoma. Equatorial Africa and Papua New Guinea are the main locations where this type is found.
Human Immunodeficiency Virus (HIV): Burkitt lymphoma and human immunodeficiency virus (HIV) are related. Please note that having EBV or HIV does not guarantee that one will get this kind of cancer.
As Burkitt lymphoma advances, weakness and weariness may occur. HIV may also present with these symptoms, making it a condition that medical professionals need to rule out before a diagnosis can be made.Genetics: Genetic mutations affecting genes like the MYC gene cause nearly all cases of Burkitt lymphoma. Researchers don't know what causes the alterations in the genes that produce this particular type of Burkitt's non-Hodgkin lymphoma, but they are not hereditary.
Risk factors change depending on where one resides. According to research, Burkitt's lymphoma is the most prevalent childhood cancer in areas with a high prevalence of malaria, such as Africa. Listed below are the major risk factors involved in Burkitt's lymphoma.
Immune System Weakness: Burkitt non-Hodgkin's lymphoma is more likely to develop in those with immune system deficiencies.
Geographical Distribution: Burkitt lymphoma manifests distinct geographic patterns. In equatorial Africa, especially in areas where the spread of malaria is substantial, Burkitt lymphoma is endemic. Although sporadic Burkitt lymphoma occurs everywhere, it is more prevalent in some areas, such as the United States, Europe, and some parts of Asia.
Age: Children and young adults are most commonly affected by Burkitt’s lymphoma, with the largest prevalence between the ages of 5 and 20.
Due to the complexity of the illness and the incomplete knowledge of its precise origins, prevention measures for Burkitt lymphoma are not yet well-defined. However, there are several steps that can be taken to lower the risk of Burkitt lymphoma:
Detection: Regular check-ups and screenings can aid in the early identification of the disease in those more vulnerable to it, such as individuals with compromised immune systems.
Early Diagnosis: Early detection of Burkitt lymphoma can result in prompt treatment, increasing the likelihood of a successful cure and halting the spread of the illness to other body regions. This is why it's crucial to be aware of all the signs of lymphoma and to get help right away if any of them appear.
Healthy Lifestyle and Good Hygiene: The immune system needs to be kept strong by maintaining a healthy lifestyle and good hygiene, such as getting regular exercise, eating a balanced diet, and abstaining from smoking and excessive alcohol use. Regular hand washing can also help lower the risk of infection.
Since Burkitt lymphoma spreads so rapidly, early diagnosis and Burkitt lymphoma treatment is crucial. If Burkitt lymphoma is identified, a swollen lymph node or other suspect disease locations will undergo full or partial biopsy. A biopsy involves examining a sample of tissue through a microscope. Burkitt lymphoma will either be found to exist or not. Other tests involved in the diagnosis of Burkitt lymphoma are:
Computed Tomography (CT) Scans: The individual's pelvis, abdomen, and chest may be scanned by medical professionals to check for cancerous signs.
Positron Emission Tomography (PET) Scans: This is yet another imaging examination that aids in the search for tumors.
Cerebrospinal Fluid Cytology: Cerebrospinal fluid can be obtained by providers to screen for cancerous cells.
Lactic Dehydrogenase (LDH) Test: LDH levels in the blood are measured by medical professionals. An elevated LDH level could indicate lymphoma.
Additional tests include:
Chest X-ray
Bone marrow biopsy
Blood tests to analyse kidney and liver functions
Testing for HIV
Arranging the medical history, compiling important information, and creating a list of inquiries to ask the doctor are all necessary steps in getting ready for a Burkitt lymphoma session. To effectively prepare, one should take the following measures:
Collecting Medical Records: Gather all relevant medical information, such as Burkitt lymphoma pathology outlines, imaging scans, and the findings of earlier tests.
List All The Burkitt Lymphoma Symptoms: Even if the symptoms seem unconnected to Burkitt lymphoma, note them down. Include information about the severity of the symptoms, when they first appeared, and any circumstances that may have contributed to their onset.
Create a List of Inquiries: Make a list of questions to bring up with the doctor, such as expected risk factors, essential tests, potential side effects, and more.
Pay Attention to Pre-consultation Instructions: If the doctor has provided any specific guidelines to follow before the visit, such as fasting or stopping a certain medication, be sure to follow them.
The healthcare professional will ask a number of questions to learn more about the patient's medical history, symptoms, and general health during a consultation for Burkitt lymphoma. One can anticipate the following from a Burkitt lymphoma doctor's consultation:
Medical History Review and Physical Exam: The doctor will start by going over the patient's medical history or Burkitts lymphoma histology, which includes any existing medical conditions, any symptoms they may have been having, and any pertinent family history.
Diagnostic Testing: The doctor will conduct particular diagnostic tests like blood tests, imaging scans, and biopsy to confirm the diagnosis. If Burkitt lymphoma has been identified based on the patient's symptoms and physical examination.
Choices for Therapy: Following a Burkitt lymphoma diagnosis and stage determination, the doctor will go over the various treatment choices.
Questions and Discussion: The doctor will urge patients to ask questions and talk about any issues they may have throughout the appointment.
Asking appropriate inquiries will help the patient to better grasp the diagnosis, available treatments, and outlook while speaking with the doctor about Burkitt lymphoma. Consider asking the following queries:
What exactly is Burkitt lymphoma, and how does it impact my body?
What tests or methods were performed to confirm a Burkitt lymphoma diagnosis?
What is the stage of my Burkitt lymphoma? Can you describe what the stage entails in terms of disease severity?
What Burkitt lymphoma therapy options are available, and which one do you advise for me?
What are the treatment's objectives, and what can I expect?
How long is the treatment plan expected to last, and what does it represent?
What are the possible side effects of the prescribed treatment, and how may they be dealt with?
Are there any alternative or additional therapies that could be used besides regular treatment?
How will Burkitt lymphoma therapy affect my daily life, including job, family, and other responsibilities?
Are there any Burkitt lymphoma support groups or resources accessible for patients and their families?
Are there any dietary or lifestyle adjustments I should make during or after treatment?
Burkitt’s lymphoma requires a thorough and extensive approach to treatment. Prompt Burkitt lymphoma treatment is essential due to the cancer cells' rapid development and tendency for broad transmission. Burkitt lymphoma frequently responds very well to the intense chemotherapy regimens currently advised, and cure rates for this illness continue to be high.
Depending on whether a patient is at low or high risk, different Burkitt lymphoma treatment guidelines are available. Similar combinations of medications are used to treat diseases with low and high risk, while high-risk patients receive additional care. All of the therapies are rigorous and often involve administering high dosages of medication.
The patient will likely undergo one of the following treatment plans:
Chemotherapy: Burkitt lymphoma responds well to this treatment. The "R-CODOX-M/IVAC" regimen, which combines cyclophosphamide, vincristine, doxorubicin, methotrexate, and cytarabine, is the most widely used chemotherapy regimen.
Immunotherapy: Immunotherapy is an option for Burkitt lymphoma patients, especially those who have certain genetic abnormalities, like the MYC gene rearrangement.
Intrathecal Therapy: Burkitt lymphoma is capable of spreading to the central nervous system (CNS). Intrathecal chemotherapy is provided directly into the cerebrospinal fluid (CSF) in order to prevent or treat CNS involvement.
Radiation Therapy: Radiation therapy may be employed in some circumstances, especially when the disease only affects a small area or if chemotherapy has left some residual disease.
Stem Cell Transplantation: In some situations, doctors may recommend a stem cell transplantation when a patient doesn't react to other Burkitt Lymphoma treatments. Medical professionals may also suggest this course of therapy to patients whose Burkitt lymphoma reoccurs. In a bone marrow transplant, stem cells are taken from the newborn's umbilical blood, peripheral blood, or bone marrow to replace the damaged stem cells.
The cost of Burkitt lymphoma treatment in India varies based on several factors including the type and stage of cancer, the treatment modality used, the patient’s age, patient comorbidities, doctor’s expertise, type and location of the hospital, insurance coverage, and much more.
To know the cost of Burkitt lymphoma treatment in India, one must consult their healthcare provider. However, the below-mentioned table also provides the cost for the various treatment modalities used for Burkitt lymphoma treatment.
Treatment Options | Cost Estimate Range |
Chemotherapy | ₹ 75,000 to ₹ 2,50,000 |
Immunotherapy | ₹ 80,000 to ₹ 2,25,000 |
Radiation Therapy | ₹ 60,000 to ₹ 2,00,000 |
Stem Cell Transplant | ₹ 15,00,000 to ₹ 27,00,000 |
With improvements in Burkitt lymphoma treatment methods throughout time, Burkitt lymphoma's survival rate has considerably improved. Individual results, however, can vary depending on a number of variables, including age, illness stage, general health, and how they react to treatment.
Burkitt lymphoma is renowned for its quick development and strong chemotherapeutic response. Success rates of up to 90% have been stated, especially among children and young people, with early diagnosis and vigorous treatment.
Burkitt lymphoma typically has a favorable prognosis, especially in children and young adults. The disease responds quite well to aggressive chemotherapy treatments. Patients with limited disease (Stages I and II) typically have a better prognosis than those with advanced cancer (Stages III and IV) or central nervous system invasion.
Additional therapy options, including stem cell transplantation or innovative targeted medicines, can be examined for patients who might suffer disease relapse or who have refractory illnesses in an effort to improve the prognosis.
The prognosis for Burkitt’s lymphoma has generally improved dramatically in recent years as a result of improvements in therapeutic strategies. However, because they can change depending on the unique patient characteristics and other clinical circumstances, it is crucial to discuss the exact prognosis and treatment choices with the medical team.
Burkitt lymphoma has a deadly outlook if left untreated. This cancer is extremely fast developing. Thus, it needs to be treated right away. The most common kind of treatment is vigorous chemotherapy, which has a unique set of possible risks and side effects, including:
Fatigue
Anaemia (inadequate red blood cell production)
Immune system deficiency
Bruising and bleeding are common.
Changes in appetite and weight
Vomiting and nausea
Constipation or diarrhoea
Hair thinning
Nerve issues such as numbness
Changes in the skin and nails
Urinary alterations
Focusing on problems
Mood swings
Libido fluctuations
Fertility difficulties
A patient who develops tumour lysis syndrome may additionally go through the following complications:
Kidney injury
Muscle control loss
Seizures
Abnormal heartbeat
Burkitt lymphoma can have disastrous consequences if it is not treated right away. Here are some dangers and issues that could arise from Burkitt lymphoma that is left untreated:
Disease progression
Organ damage
Weakened immune system
Tumor lysis syndrome
Worsening of symptoms
It's critical to visit a doctor as soon as possible if one experiences any symptoms because Burkitt lymphoma is a severe tumour. Burkitt lymphoma develops rapidly into a lethal disease, in contrast to other malignancies that progress and spread slowly. Some signs of illness include:
Swollen lymph nodes
Weakness or unusual fatigue
Stomach ache
Sudden weight loss
Night Sweating
Each meal and dietary supplement is made up of a variety of active chemical components in varying ratios and concentrations. While various active elements in the same meal may be helpful in the context of Burkitt lymphoma, other active substances in foods can combine in ways that are harmful. Here are some dietary recommendations for patients with Burkitt lymphoma:
Balanced Diet: A well-rounded diet that contains a variety of nutrient-dense foods is ideal. Fruits, vegetables, entire grains, lean proteins, and healthy fats are common examples.
Fruits and Vegetables: These can be beneficial to one's immune system and overall health. Consuming at least five servings of fruits and vegetables daily is widely recommended.
Whole Grains: Patients should choose whole grains over refined grains such as whole wheat, brown rice, quinoa, and oats. When opposed to refined grains, whole grains include more fiber, vitamins, and minerals.
Hydration: It is critical for patients to stay hydrated by having plenty of water and other fluids. This is especially crucial during cancer treatment because some medications might cause dehydration or disrupt the body's fluid balance.
Burkitt lymphoma is a kind of non-Hodgkin lymphoma that is extremely aggressive and mostly attacks B cells. It is distinguished by quickly developing tumors, which frequently manifest as enlarged lymph nodes. Treatment usually entails intense chemotherapy, and with timely and competent management, the outcome is generally good.
At HexaHealth, our devoted team of medical specialists is committed to helping people with Burkitt lymphoma. From the initial diagnosis to continuing maintenance, we offer complete care. We provide individualized, empathetic support to those impacted by Burkitt lymphoma, whether it be by assisting patients through diagnostic procedures, going over available treatments, or offering supportive care. To find out more about our offerings and how we may help you on your path to better health, get in touch with us.
Hodgkin Non Hodgkin Lymphoma Treatment |
Is Lymphoma Curable |
Types of Lymphoma |
Difference between Hodgkin and Non-Hodgkin Lymphoma |
Hodgkins Lymphoma |
Diffuse Large B Cell Lymphoma |
Burkitt lymphoma is a kind of non-Hodgkin lymphoma that affects B cells. It is an uncommon type of cancer that typically begins in people's organs, such as their abdomen or spleens.
Burkitt lymphoma's key characteristics include a soft-tissue tumour in the jaw or surrounding facial bones, rapidly expanded cervical lymph nodes, abdominal lumps, and ascites.
Burkitt lymphoma is caused by chromosomal translocations involving the Myc gene. A chromosome translocation occurs when a chromosome is damaged, allowing it to connect with sections of other chromosomes. The classic Burkitt lymphoma translocation involves chromosome 8, which contains the Myc gene.
More than half of all cases of endemic (African) Burkitt lymphoma (eBL) involve the jaw and facial bone (orbit). Sporadic Burkitt lymphoma (sBL) most commonly manifests as abdominal malignancies involving the bone marrow.
The existence of monomorphic, medium-sized lymphoid cells with significant mitotic activity characterizes Burkitt lymphoma pathology outlines. Due to the abundance of macrophages phagocytosing apoptotic debris, the cells generally have a "starry sky" look.
Burkitt lymphoma's histology exhibits layers of monomorphic medium lymphocytes with an elevated level of mitosis and many apoptotic bodies, known as a "starry-sky" appearance. Burkitt lymphoma is characterised by a t(8;14) translocation of the MYC gene.
The appearance of Burkitt lymphoma is similar to a starry sky. This is due to the presence of macrophages (innate immune cells), which are visible in the inset and have relatively clear cytoplasm (a dense fluid encased by the cell membrane and filling each cell).
Typically, tumour cells in Burkitt lymphoma have an oval or spherical form. The ratio of nucleus to cytoplasm in these monomorphic cells is relatively high. The tumour cells' distinctive microscopic appearance is a result of their round shape.
Burkitt's lymphoma tumor is caused by the factors listed below.
Chromosomal translocation
Overexpression of c-Myc oncogene
Epstein-Barr virus (EBV) infection
Immunodeficiency
Genetic predispositions
Epstein-Barr virus (EBV) is a known cause of sporadic Burkitt lymphoma. The type of virus that triggers mononucleosis (glandular fever) is this one.
Based on various circumstances, there are varying Burkitt lymphoma risks. The risk factors linked to Burkitt Lymphoma are:
In equatorial Africa, particularly in regions with high malaria prevalence, the endemic variant is more common.
Burkitt lymphoma is more likely to develop in those with weakened immune systems, such as people with HIV/AIDS.
Those between the ages of 5 and 20 have the highest incidence of Burkitt lymphoma.
The symptoms of Burkitt lymphoma appear unexpectedly and progressively worsen. The following are the main symptoms:
Abdominal pain
Weakness and fatigue
Swollen lymph nodes
Nausea and vomiting
Weakness and fatigue
Fever
Unusual weight loss
Night sweats
This Burkitt lymphoma illness can be categorised simply into four distinct stages:
Stage I: One in which there is just one location in the body where the cancer is present.
Stage II: There are two locations where Burkitt's lymphomas are found, and both locations are on the same side of the diaphragm.
Stage III: Lymph nodes or other areas on both sides of the diaphragm are affected
Stage IV: Lymphomas in the brain or bone marrow (central nervous system) are included
The jaw and facial bone are most frequently affected by Endemic Burkitt lymphoma, while Sporadic Burkitt lymphoma usually appears as bone marrow-involved abdominal malignancies.
The lymphatic system can spread Burkitt lymphoma to surrounding lymph nodes, and the circulation can carry it to faraway organs and tissues. The central nervous system, or CNS, includes the brain and spinal cord, is frequently affected.
Before making a diagnosis, the doctors will need to conduct a variety of tests. The primary tests consist include:
Physical examination (searching for lumps)
Blood tests
MRI, PET, and CT Scans
Lumbar puncture tests to check for lymphoma cells within the spinal fluid.
Complete blood count (CBC), blood chemistry analyses, immunohistochemistry, HIV blood test, flow cytometric analysis, and cytogenetics are some of the laboratory tests used to diagnose Burkitt's lymphoma.
One of the following therapy programs will likely be used on the Burkitt lymphoma patient:
Chemotherapy
Immunotherapy
Radiotherapy
Intrathecal Therapy
The signs and symptoms of Burkitt lymphoma appear unexpectedly and worsen swiftly. Chemotherapy is used extensively by medical professionals to treat Burkitt lymphoma. In all phases of this aggressive disease, intensive systemic chemotherapy is the preferred course of action.
Burkitt lymphoma responds quite well to treatment, and individuals who are able to endure extremely demanding combination chemotherapy regimens frequently recover.
A starry-sky look is a hallmark of the disease Burkitt lymphoma starry sky appearance is caused by the presence of macrophages, which can be seen in the inset to have comparatively clean cytoplasm. This growth is made up of mature B cells. In the darkened region of a germinal centre, the immunophenotype resembles that of typical B cells.
The t(8;14) chromosomal translocation mutation, which is linked to Burkitt lymphoma, matters for the progression of the illness. The c-Myc gene on chromosome 8 and the immunoglobulin(plasma cell-produced glycoproteins) gene on chromosome 14 are rearranged as part of this translocation. The c-Myc oncogene, a transcription element that contributes to the control of cell growth and division, is overexpressed as a result of the burkitt lymphoma mutation.
Yes, there are particular Burkitt lymphoma treatment recommendations. These recommendations often call for aggressive chemotherapy regimens that are customised to the patient's specific circumstances and disease subtype. The treatment strategy may also include the use of additional treatments, including radiation therapy and CNS prophylaxis.
While unclassifiable B-cell lymphoma frequently has a MYC-complex karyotype, Burkitt lymphoma frequently has a MYC-simple karyotype.
Non-Hodgkin B-cell lymphoma that is aggressive is called Burkitt lymphoma (BL). Human immunodeficiency virus (HIV), Epstein-Barr virus (EBV), and chromosomal translocations that result in the overexpression of the oncogene c-myc are all linked to the illness.
A prolonged survival rate of over 90% is typical for the treatment of limited-stage (stage I and II) Burkitt lymphomas. Approximately 80% to 90% of children and teenagers with more severe (stage III or IV) Burkitt lymphoma will survive in the long run.
Yes, Burkitt lymphoma is highly curable, particularly in children and young people. Burkitt lymphoma responds very well to rigorous chemotherapy regimens because of its aggressive nature. For the best results, early detection and prompt treatment is essential.
Burkitt lymphoma in stage 4, which shows the disease has progressed to numerous organs or distant areas, is regarded as advanced. Even in cases when the cancer has reached stage 4, it can frequently be effectively treated with the right Burkitt lymphoma treatment, which may include chemotherapy and other supportive measures. People with stage 4 Burkitt lymphoma should speak with their healthcare provider since they can offer individualised treatment recommendations and prognosis data based on specific circumstances.
There is no known way to prevent Burkitt's lymphoma. However, it can be effectively avoided by following these measures:
Regular check-ups and screenings
Early Diagnosis
Healthy lifestyle and good hygiene
Tumours that develop in different places of the body as a result of Burkitt lymphoma can be painful and uncomfortable. Lymph nodes, which are found all over the body, might expand as a result of lymphoma.
Yes, adults with Burkitt lymphoma are believed to be cured. Numerous adults with Burkitt lymphoma are able to accomplish recovery and long-term survival with the use of aggressive chemotherapy regimens designed specifically for their condition.
A significant percentage of adults with Burkitt lymphoma can be recovered with the right treatment. However, the prognosis can vary depending on personal factors like age, general health, and disease characteristics.
Burkitt lymphoma makes up 30% of children's non-Hodgkin lymphomas but just 1% of adult lymphomas. Burkitt's lymphoma is typically diagnosed in adults between 30 and 50 years, whereas children are typically diagnosed between ages 5 and 10 years.
Although Burkitt lymphoma is not inherited, it is linked to other conditions that may be related to the disease. Immune system disorders can be inherited by some individuals. These genetic conditions make it difficult for the immune system to combat infections.
Burkitt's tumour is another term for Burkitt lymphoma. When referring to the same disease group, the terms "Burkitt's tumour" and "Burkitt lymphoma" are occasionally used interchangeably.
Burkitt lymphoma is a fast-growing human tumour that is known to be linked to weakened immunity and is quickly lethal if ignored; risks include:
Disease development
Organ injury
Compromised immune system
Tumour lysis syndrome
Worsening of symptoms
Myth: Burkitt lymphoma is a common type of cancer.
Fact: Burkitt lymphoma is a very rare type of non-Hodgkin lymphoma, accounting for about 1% to 2% of all lymphomas globally. However, it is more common in specific locations, such as equatorial Africa, where it is related to Epstein-Barr virus (EBV) infection.
Myth:Burkitt’s lymphoma is only found in children.
Fact: Burkitt lymphoma is most typically diagnosed in children and young adults, but it can occur in anyone at any age.
Myth: Burkitt lymphoma is a cancer that advances slowly.
Fact: Not true! Burkitt lymphoma spreads quickly. It is one of the human tumours that grow the fastest, with cells dividing swiftly and tumours rapidly doubling in size.
All the articles on HexaHealth are supported by verified medically-recognized sources such as; peer-reviewed academic research papers, research institutions, and medical journals. Our medical reviewers also check references of the articles to prioritize accuracy and relevance. Refer to our detailed editorial policy for more information.
Last Updated on: 12 July 2024
MBBS, DNB General Surgery, Fellowship in Minimal Access Surgery, FIAGES
12 Years Experience
Dr Aman Priya Khanna is a well-known General Surgeon, Proctologist and Bariatric Surgeon currently associated with HealthFort Clinic, Health First Multispecialty Clinic in Delhi. He has 12 years of experience in General Surgery and worke...View More
She has extensive experience in content and regulatory writing with reputed organisations like Sun Pharmaceuticals and Innodata. Skilled in SEO and passionate about creating informative and engaging medical conten...View More
Book Consultation
Latest Health Articles